Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies.
The company specializes in providing contract development and manufacturing services (CDMO) to pharmace…
Analysis
Middle-of-the-road
Bachem Holding AG sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.
Valuation data is not available for this company.
Growth is solid; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202373
89
2023202420252026
All-time high
96
Mar 2026
All-time low
31
Nov 2025
Average rank
68
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
26
13
17
28
Price/Earnings
18
33
30
11
Price/Book
52
40
37
13
Dividend Yield
77
67
66
63
Value (overall)
51
70
34
35
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.